Clinical trials
Neoplasms by Site trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 3 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
| Completed | 13 |
| Terminated | 6 |
| Active, not recruiting | 4 |
| Unknown status | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Research UK | 7 |
| AstraZeneca | 3 |
| Eli Lilly and Company | 3 |
| Hoffmann-La Roche | 3 |
| Royal Marsden NHS Foundation Trust | 3 |
| Steba Biotech S.A. | 3 |
| Bristol-Myers Squibb | 2 |
| Daiichi Sankyo | 2 |
| Novartis Pharmaceuticals | 2 |
| University College, London | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms by Site | 41 |
| Neoplasms | 36 |
| Neoplasms by Histologic Type | 15 |
| Carcinoma | 14 |
| Carcinoma, Non-Small-Cell Lung | 12 |
| Lung Diseases | 10 |
| Lung Neoplasms | 10 |
| Respiratory Tract Diseases | 10 |
| Respiratory Tract Neoplasms | 10 |
| Bronchial Neoplasms | 9 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.